1-17 of 17
Izidore S. Lossos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium

Jonathan R Day, Melissa C. Larson, Urshila Durani, Jean L Koff, Yucai Wang, Thomas M. Habermann, Izidore S Lossos, Loretta J. Nastoupil, Christopher S Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B Cohen, Brad S. Kahl, Jia Ruan, Richard Burack, Jonathan W. Friedberg, James R Cerhan, Christopher R. Flowers, Brian L Link, Matthew J. Maurer, Carla Casulo
Journal: Blood Advances
Blood Adv bloodadvances.2024014053.
https://doi.org/10.1182/bloodadvances.2024014053
Published: 2024
Includes: Supplemental data
Journal Articles

Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature

Clinical Trials & Observations
Côme Bommier, Brian K. Link, Brianna J. Gysbers, Matthew J. Maurer, Melissa C. Larson, Arushi Khurana, Yucai Wang, Carrie A. Thompson, Dai Chihara, Juan P. Alderuccio, Jean L. Koff, Narendranath Epperla, Annarita Conconi, Izidore S. Lossos, Grzegorz S. Nowakowski, Andrew L. Feldman, Thomas M. Habermann, Rebecca L. King, James R. Cerhan
Journal: Blood Advances
Blood Adv (2024) 8 (23): 5939–5948.
https://doi.org/10.1182/bloodadvances.2024013188
Published: 2024
Includes: Supplemental data
Journal Articles

Transformation of marginal zone lymphoma to Hodgkin lymphoma

Kamilia N. Moalem, Juan Pablo Alderuccio, Côme Bommier, Thomas Habermann, Brian K. Link, James R. Cerhan, Jorge Florindez, Izidore S. Lossos
Journal: Blood Advances
Blood Adv (2024) 8 (17): 4559–4562.
https://doi.org/10.1182/bloodadvances.2024013434
Published: 2024
Journal Articles

Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population–based analysis

Clinical Trials & Observations
Jorge A. Florindez, Dai Chihara, Isildinha M. Reis, Izidore S. Lossos, Juan Pablo Alderuccio
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4423–4432.
https://doi.org/10.1182/bloodadvances.2024013499
Published: 2024
Includes: Supplemental data
Journal Articles

Defining primary refractory large B-cell lymphoma

Allison M. Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew J. Maurer, Amy Ayers, Brad S. Kahl, Peter Martin, Jonathon B. Cohen, Carla Casulo, Izidore S. Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M. Habermann, Thomas E. Witzig, Christopher R. Flowers, James R. Cerhan, Loretta J. Nastoupil, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3402–3415.
https://doi.org/10.1182/bloodadvances.2024012760
Published: 2024
Includes: Supplemental data
Journal Articles

A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)

Clinical Trials & Observations
Tycel J. Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S. Lossos, Pier Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter Johnson
Journal: Blood Advances
Blood Adv (2024) 8 (4): 867–877.
https://doi.org/10.1182/bloodadvances.2023010648
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Raphael E. Steiner, Steven R. Hwang, Arushi Khurana, Thomas M. Habermann, Narendranath Epperla, Kaitlin Annunzio, Pamela Blair Allen, Katelin Baird, Darina Paulino, Juan Pablo Alderuccio, Izidore S. Lossos, Kevin David, Andrew M. Evens, Karan Pandya, Steven M. Bair, Manali Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Ryan Lynch, Stephen Smith, Lei Feng, Mansoor Noorani, Sairah Ahmed, Ranjit Nair, Francisco Vega, Susan Wu, Penny Fang, Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Hun J. Lee
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7485–7493.
https://doi.org/10.1182/bloodadvances.2023010700
Published: 2023
Includes: Supplemental data
Journal Articles

Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study

Adam J. Olszewski, Tycel J. Phillips, Marc S. Hoffmann, Philippe Armand, Tae Min Kim, Dok Hyun Yoon, Amitkumar Mehta, Richard Greil, Jason Westin, Izidore S. Lossos, Javier L. Munoz, Jason Sit, Michael C. Wei, Annie Yang, Vivian Chen, Enkhtsetseg Purev, Donald L. Yee, Ulrich Jaeger
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6055–6065.
https://doi.org/10.1182/bloodadvances.2023010840
Published: 2023
Includes: Supplemental data
Journal Articles

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303

David A. Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F. Cashen, Neha Mehta-Shah, Brad S. Kahl, Nancy L. Bartlett, Juan P. Alderuccio, Izidore S. Lossos, Sarah L. Ondrejka, Eric D. Hsi, Peter Martin, John P. Leonard, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5524–5539.
https://doi.org/10.1182/bloodadvances.2023010779
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

Clinical Trials & Observations
Anas Younes, John M. Burke, Bruce D. Cheson, Catherine S. Diefenbach, Silvia Ferrari, Uwe H. Hahn, Eliza A. Hawkes, Cyrus Khan, Izidore S. Lossos, Gerardo Musuraca, Monica Tani, Umberto Vitolo, Sam Yuen, Aparna Raval, Mahesh Shivhare, Tina G. Nielsen, Gila Sellam, Jeff P. Sharman
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1488–1495.
https://doi.org/10.1182/bloodadvances.2022008344
Published: 2023
Includes: Supplemental data
Journal Articles

Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis

Danny Luan, Tolulope Fatola, Ahmed Toure, Christopher R. Flowers, Brian Link, Jonathan W. Friedberg, Jonathon B. Cohen, Brad Kahl, Izidore S. Lossos, Loretta Nastoupil, Matthew J. Maurer, James R. Cerhan, Peter Martin
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4413–4423.
https://doi.org/10.1182/bloodadvances.2022007687
Published: 2022
Includes: Supplemental data
Journal Articles

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

Clinical Trials & Observations
R. Andrew Harkins, Sharvil P. Patel, Michelle J. Lee, Jeffrey M. Switchenko, Stephen M. Ansell, Nancy L. Bartlett, Kristie A. Blum, Amanda F. Cashen, Carla Casulo, Jonathan W. Friedberg, Patrick B. Johnston, Brad S. Kahl, John P. Leonard, Brian K. Link, Izidore S. Lossos, Peter Martin, Matt J. Maurer, Neha Mehta-Shah, Patrick M. Reagan, Jason R. Westin, Jean L. Koff, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2745–2756.
https://doi.org/10.1182/bloodadvances.2021006504
Published: 2022
Includes: Supplemental data
Journal Articles

An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma

Clinical Trials & Observations
Juan Pablo Alderuccio, Luca Arcaini, Marcus P. Watkins, Anne W. Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B. Alpert, Adam J. Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J. Castillo, Lisa Argnani, Timothy J. Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M. Reis, Deukwoo Kwon, Jonathan S. Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian K. Link, Constantine N. Logothetis, Alex F. Herrera, Jonathan W. Friedberg, Brad S. Kahl, Stefano Luminari, Pier Luigi Zinzani, Izidore S. Lossos
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2035–2044.
https://doi.org/10.1182/bloodadvances.2021006844
Published: 2022
Journal Articles

HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins

Xiaoyu Jiang, XiaoQing Lu, Andrew J. Gentles, Dekuang Zhao, Seth A. Wander, Yu Zhang, Yasodha Natkunam, Joyce Slingerland, Isildinha M. Reis, Brian Rabinovich, Midhat H. Abdulreda, Vincent T. Moy, Izidore S. Lossos
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5072–5085.
https://doi.org/10.1182/bloodadvances.2021004304
Published: 2021
Includes: Supplemental data
Journal Articles

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Clinical Trials & Observations
Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, Graham P. Collins, Alexey V. Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Suchitra Sundaram, Nishitha Reddy, Alessia Dalla Pria, Christopher D’Angelo, Umar Farooq, David A. Bond, Stephanie Berg, Michael C. Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Shireen Kassam, Maryam Yazdy, Emma Rabinovich, Frank A. Post, Gaurav Varma, Reem Karmali, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine Diefenbach, Allandria Straker-Edwards, Andreas Klein, Kristie A. Blum, Kirsten Marie Boughan, Agrima Mian, Bradley M. Haverkos, Victor M. Orellana-Noia, Vaishalee P. Kenkre, Adam Zayac, Seth M. Maliske, Narendranath Epperla, Paolo Caimi, Scott E. Smith, Manali Kamdar, Parameswaran Venugopal, Tatyana A. Feldman, Daniel Rector, Stephen D. Smith, Andrzej Stadnik, Craig A. Portell, Yong Lin, Seema Naik, Silvia Montoto, Izidore S. Lossos, Kate Cwynarski
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2852–2862.
https://doi.org/10.1182/bloodadvances.2021004458
Published: 2021
Includes: Supplemental data
Journal Articles

Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling

Xiaoyu Jiang, Xiaoqing Lu, Yu Zhang, Leda Lacaria, Brett J. Schuchardt, David C. Mikles, Marco Magistri, Idoia García-Ramírez, Isidro Sanchez-Garcia, Amjad Farooq, Ramiro E. Verdun, Midhat H. Abdulreda, Vincent T. Moy, Izidore S. Lossos
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2286–2297.
https://doi.org/10.1182/bloodadvances.2018016162
Published: 2019
Includes: Supplemental data
Journal Articles

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

Clinical Trials & Observations
Monika Pilichowska, Stefania Pittaluga, Judith A. Ferry, Jessica Hemminger, Hong Chang, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, Jeremy S. Abramson, Athena Kritharis, Francisco J. Hernandez-Ilizaliturri, Izidore S. Lossos, Oliver W. Press, Timothy S. Fenske, Jonathan W. Friedberg, Julie M. Vose, Kristie A. Blum, Deepa Jagadeesh, Bruce Woda, Gaurav K. Gupta, Randy D. Gascoyne, Elaine S. Jaffe, Andrew M. Evens
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2600–2609.
https://doi.org/10.1182/bloodadvances.2017009472
Published: 2017
Includes: Supplemental data